Skip to content
cinenetworth logo
  • Home
  • About Us
  • Blog
  • Contact Us
cinenetworth logo

Sam Waksal Net Worth (Updated 2026).

Written ByJason S Hours Published onJuly 28, 2025

Sam Waksal, a name that became synonymous with biotechnology innovation, began his career in the early 1980s. Born in Israel, Waksal completed his undergraduate and graduate studies in biochemistry and immunology at the prestigious Weizmann Institute of Science. After immigrating to the United States, he secured a position as a research scientist at the Memorial Sloan Kettering Cancer Center in New York City. It was here that Waksal’s groundbreaking work on monoclonal antibodies and cancer treatment began to garner attention, setting the stage for his future accomplishments.

Table Of Contents

  • Sam Waksal’s Current Net Worth (2025)
  • Sam Waksal’s Career
  • Other Ventures
  • Assets
  • Annual Income
  • Frequently Asked Questions about  Sam Waksal
  • Frequently Asked Questions: Sam Waksal Net Worth
  • 1. What is Sam Waksal’s net worth?
  • 2. How did Sam Waksal make his money?
  • 3. What is Sam Waksal’s background?
  • 4. What is Sam Waksal known for?
  • 5. What was the insider trading scandal about?
  • 6. What was the outcome of the insider trading case?
  • 7. When was Sam Waksal released from prison?
  • 8. What has Sam Waksal been doing since his release from prison?
  • 9. Has Sam Waksal paid his debt to society?
  • 10. What can we learn from Sam Waksal’s story?

Sam Waksal’s Current Net Worth (2025)

As of 2025, Sam Waksal’s net worth is estimated to be around $100 million, according to the latest available information. This figure is a reflection of his successful career in the pharmaceutical industry and his various business ventures.

Sam Waksal’s Career

Sam Waksal is a prominent figure in the pharmaceutical industry, known for his role as the founder and former CEO of ImClone Systems. He started his career as a research scientist and later moved into business, founding several biotechnology companies. Waksal’s career has been marked by both success and controversy, including his involvement in a high-profile insider trading scandal in the early 2000s.

Other Ventures

In addition to his work in the pharmaceutical industry, Waksal has also ventured into other areas. He has invested in real estate, including properties in New York City and the Hamptons. He has also been involved in the art world, with a particular interest in photography. Waksal’s diverse interests have helped him to build a broad portfolio of investments.

Assets

Waksal’s assets include a significant stake in Kadmon Holdings, a biopharmaceutical company he founded in 2010. He also owns a number of properties, including a luxury apartment in Manhattan and a home in the Hamptons. Waksal’s art collection, which includes works by prominent photographers, is another notable asset.

Annual Income

Waksal’s annual income varies depending on the success of his business ventures and investments. As of 2025, his estimated annual income is around $10 million. This figure is subject to change and may not include potential earnings from future ventures or investments.

Frequently Asked Questions about  Sam Waksal

Frequently Asked Questions: Sam Waksal Net Worth

1. What is Sam Waksal’s net worth?

Sam Waksal’s net worth is estimated to be around $50 million.

2. How did Sam Waksal make his money?

Sam Waksal made his fortune through his pharmaceutical company, ImClone Systems, which he founded in 1984. He also served as its CEO until 2002.

3. What is Sam Waksal’s background?

Sam Waksal was born in Israel and moved to the United States in 1974. He received his Ph.D. in biochemistry from the University of California, Los Angeles.

4. What is Sam Waksal known for?

Sam Waksal is known for founding ImClone Systems and for his involvement in a high-profile insider trading scandal in 2002.

5. What was the insider trading scandal about?

The scandal involved Sam Waksal tipping off his daughter, Aliza, and other family members to sell their shares in ImClone Systems before the FDA rejected the company’s cancer drug, Erbitux. This resulted in a significant drop in the company’s stock price.

6. What was the outcome of the insider trading case?

Sam Waksal pleaded guilty to securities fraud and perjury in 2002. He was sentenced to seven years and three months in prison and ordered to pay a $4.3 million fine.

7. When was Sam Waksal released from prison?

Sam Waksal was released from prison in 2009 after serving about five years.

8. What has Sam Waksal been doing since his release from prison?

After his release, Sam Waksal has been involved in various business ventures, including a biotechnology company called Kadmon Holdings, which he founded in 2010.

9. Has Sam Waksal paid his debt to society?

Yes, Sam Waksal has paid his debt to society by serving his prison sentence and paying the fines imposed on him.

10. What can we learn from Sam Waksal’s story?

Sam Waksal’s story serves as a reminder that unethical behavior can have severe consequences, both personally and professionally. It also highlights the importance of integrity and honesty in business dealings.

Jason S

Hi, I am Jason. An entertainment writer and a dad. I like to write about celebrities and love spending time with my family.

Post navigation

Previous Previous
Chris Thieneman Net Worth (Updated 2026).
NextContinue
Saratoga Water Net Worth (Updated 2026).
  • privacy policy
  • terms and conditions
  • legal disclaimer
  • Contact Us

© 2026 Cine Net Worth - Celebritie's Net Worth, Annual Income & Assets.

  • Home
  • About Us
  • Blog
  • Contact Us